Lavo Life Sciences uses AI to predict drug molecule crystal structures on a large scale. Their software allows for efficient analysis of drug behavior at the atomic level to develop therapies quickly. Lavo's chemists and engineers developed techniques to make pharmaceutical property prediction cost-effective, aiming to speed up drug development. With startup status and venture backing, Lavo seeks to partner to further drug research. Their tools simulate drug behaviors to save costs and hasten drug development.